Nutrition and Bone Health in Space

Part of the Nutrition and Health book series (NH)


The effect of weightlessness on the human skeletal system is one of the greatest concerns in safely extending space missions. The ability to understand and counteract weightlessness-induced bone mineral loss will be vital to crew health and safety during and after extended-duration space station and exploration missions. Research on bone mineral loss during space flight has gone on for more than half a century, and recent studies have shown significant progress in developing countermeasures that have proved to be effective, including good nutrition and exercise. We review the history of this research here and provide a summary of recent and ongoing studies, including efforts to counteract bone and calcium loss resulting from weightlessness.


Microgravity Space flight Weightlessness Calcium Vitamin D Protein Omega-3 fatty acids Iron Vitamin K 


  1. 1.
    Morey-Holton E, Whalen R, Arnaud S, Van Der Meulen M. The skeleton and its adaptation to gravity. In: Fregly M, Blatteis C, editors. Environmental physiology, vol 1. Handbook of physiology. New York: Oxford University Press; 1996. p. 691–719.Google Scholar
  2. 2.
    Heer M, Kamps N, Biener C, Korr C, Boerger A, Zittermann A, et al. Calcium metabolism in microgravity. Eur J Med Res. 1999;4:357–60.PubMedGoogle Scholar
  3. 3.
    Arnaud SB, Schneider VS, Morey-Holton E. Effects of inactivity on bone and calcium metabolism. In: Sandler H, Vernikos J, editors. Inactivity: physiological effects. Orlando, FL: Academic Press, Inc.; 1986. p. 49–76.Google Scholar
  4. 4.
    Schneider VS, McDonald J. Skeletal calcium homeostasis and countermeasures to prevent disuse osteoporosis. Calcif Tissue Int. 1984;36 Suppl 1:S151–4.PubMedGoogle Scholar
  5. 5.
    Smith SM, Zwart SR. Nutritional biochemistry of spaceflight. In: Makowsky G, editor. Advances in clinical chemistry, vol. 46. Burlington, VT: Academic; 2008. p. 87–130.Google Scholar
  6. 6.
    Sibonga JD, Cavanagh PR, Lang TF, LeBlanc AD, Schneider VS, Shackelford LC, et al. Adaptation of the skeletal system during long-duration spaceflight. Clin Rev Bone Miner Metab. 2008;5:249–61.Google Scholar
  7. 7.
    Sibonga JD, Evans HJ, Sung HG, Spector ER, Lang TF, Oganov VS, et al. Recovery of spaceflight-induced bone loss: bone mineral density after long-duration missions as fitted with an exponential function. Bone. 2007;41:973–8.PubMedGoogle Scholar
  8. 8.
    Smith SM, Heer M. Calcium and bone metabolism during space flight. Nutrition. 2002;18:849–52.PubMedGoogle Scholar
  9. 9.
    Holick MF. Microgravity-induced bone loss - will it limit human space exploration? Lancet. 2000;355:1569–70.PubMedGoogle Scholar
  10. 10.
    Iwamoto J, Takeda T, Sato Y. Interventions to prevent bone loss in astronauts during space flight. Keio J Med. 2005;54:55–9.PubMedGoogle Scholar
  11. 11.
    Ohshima H, Mukai C. Bone metabolism in human space flight and bed rest study. Clin Calcium. 2008;18:1245–53.PubMedGoogle Scholar
  12. 12.
    Zorbas YG, Kakuris KK, Deogenov VA, Yerullis KB. Inadequacy of calcium supplements to normalize muscle calcium deficiency in healthy subjects during prolonged hypokinesia. Nutrition. 2008;24:217–23.PubMedGoogle Scholar
  13. 13.
    LeBlanc A, Schneider V, Spector E, Evans H, Rowe R, Lane H, et al. Calcium absorption, endogenous excretion, and endocrine changes during and after long-term bed rest. Bone. 1995;16(4 Suppl):301S–4.PubMedGoogle Scholar
  14. 14.
    Smith SM, Wastney ME, Morukov BV, Larina IM, Nyquist LE, Abrams SA, et al. Calcium metabolism before, during, and after a 3-mo spaceflight: kinetic and biochemical changes. Am J Physiol. 1999;277:R1–10.PubMedGoogle Scholar
  15. 15.
    Smith SM, Wastney ME, O’Brien KO, Morukov BV, Larina IM, Abrams SA, et al. Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the Mir space station. J Bone Miner Res. 2005;20:208–18.PubMedGoogle Scholar
  16. 16.
    Zittermann A, Heer M, Caillot-Augusso A, Rettberg P, Scheld K, Drummer C, et al. Microgravity inhibits intestinal calcium absorption as shown by a stable strontium test. Eur J Clin Invest. 2000;30:1036–43.PubMedGoogle Scholar
  17. 17.
    Hulley SB, Vogel JM, Donaldson CL, Bayers JH, Friedman RJ, Rosen SN. The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest. J Clin Invest. 1971;50:2506–18.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Hantman DA, Vogel JM, Donaldson CL, Friedman R, Goldsmith RS, Hulley SB. Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate. J Clin Endocrinol Metab. 1973;36:845–58.PubMedGoogle Scholar
  19. 19.
    Zwart SR, Smith SM. The impact of space flight on the human skeletal system and potential nutritional countermeasures. Int SportMed J. 2005;6:199–214.Google Scholar
  20. 20.
    Oganov V, Rakhmanov A, Novikov V, Zatsepin S, Rodionova S, Cann C. The state of human bone tissue during space flight. Acta Astronaut. 1991;23:129–33.PubMedGoogle Scholar
  21. 21.
    Smith Jr MC, Rambaut PC, Vogel JM, Whittle MW. Bone mineral measurement—experiment M078. In: Johnston RS, Dietlein LF, editors. Biomedical results from Skylab NASA Special Pub. SP-377. Washington, DC: National Aeronautics and Space Administration; 1977. p. 183–90.Google Scholar
  22. 22.
    Stupakov GP, Kazeykin VS, Kozlovskiy AP, Korolev VV. Evaluation of changes in human axial skeletal bone structures during long-term spaceflights. Kosm Biol Aviakosm Med. 1984;18(2):33–7.PubMedGoogle Scholar
  23. 23.
    Whedon GD. Disuse osteoporosis: physiological aspects. Calcif Tissue Int. 1984;36:S146–50.PubMedGoogle Scholar
  24. 24.
    Rambaut PC, Goode AW. Skeletal changes during space flight. Lancet. 1985;2:1050–2.PubMedGoogle Scholar
  25. 25.
    Whedon GD, Lutwak L, Rambaut PC, Whittle MW, Smith MC, Reid J, et al. Mineral and nitrogen metabolic studies, experiment M071. In: Johnston RS, Dietlein LF, editors. Biomedical results from Skylab NASA Special Pub. SP. 377. Washington, DC: National Aeronautics and Space Administration; 1977. p. 164–74.Google Scholar
  26. 26.
    Weaver CM, LeBlanc A, Smith SM. Calcium and related nutrients in bone metabolism. In: Lane HW, Schoeller DA, editors. Nutrition in spaceflight and weightlessness models. Boca Raton, FL: CRC Press; 2000. p. 179–201.Google Scholar
  27. 27.
    LeBlanc A, Schneider V, Shackelford L, West S, Oganov V, Bakulin A, et al. Bone mineral and lean tissue loss after long duration space flight. J Musculoskelet Neuronal Interact. 2000;1:157–60.PubMedGoogle Scholar
  28. 28.
    Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, Rehaillia M, et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet. 2000;355:1607–11.PubMedGoogle Scholar
  29. 29.
    Rambaut PC, Johnston RS. Prolonged weightlessness and calcium loss in man. Acta Astronaut. 1979;6:1113–22.PubMedGoogle Scholar
  30. 30.
    Parfitt AM. Bone effects of space flight: analysis by quantum concept of bone remodelling. Acta Astronaut. 1981;8:1083–90.PubMedGoogle Scholar
  31. 31.
    Grigoriev AI, Oganov VS, Bakulin AV, Poliakov VV, Voronin LI, Morgun VV, et al. Clinical and physiological evaluation of bone changes among astronauts after long-term space flights. Aviakosm Ekolog Med. 1998;32:21–5.PubMedGoogle Scholar
  32. 32.
    Whitson P, Pietrzyk R, Pak C, Cintron N. Alterations in renal stone risk factors after space flight. J Urol. 1993;150:803–7.PubMedGoogle Scholar
  33. 33.
    Whitson PA, Pietrzyk RA, Pak CY. Renal stone risk assessment during Space Shuttle flights. J Urol. 1997;158:2305–10.PubMedGoogle Scholar
  34. 34.
    Pietrzyk RA, Feiveson AH, Whitson PA. Mathematical model to estimate risk of calcium-containing renal stones. Miner Electrolyte Metab. 1999;25:199–203.PubMedGoogle Scholar
  35. 35.
    Pietrzyk RA, Jones JA, Sams CF, Whitson PA. Renal stone formation among astronauts. Aviat Space Environ Med. 2007;78:A9–13.PubMedGoogle Scholar
  36. 36.
    Zerwekh JE. Nutrition and renal stone disease in space. Nutrition. 2002;18:857–63.PubMedGoogle Scholar
  37. 37.
    Smith SM, Zwart SR, Heer M, Hudson EK, Shackelford L, Morgan JL. Men and women in space: bone loss and kidney stone risk after long-duration spaceflight. J Bone Miner Res. 2014;29(7):1639–45.PubMedGoogle Scholar
  38. 38.
    Lang T, LeBlanc A, Evans H, Lu Y, Genant H, Yu A. Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res. 2004;19:1006–12.PubMedGoogle Scholar
  39. 39.
    LeBlanc AD, Spector ER, Evans HJ, Sibonga JD. Skeletal responses to space flight and the bed rest analog: a review. J Musculoskelet Neuronal Interact. 2007;7:33–47.PubMedGoogle Scholar
  40. 40.
    Leach CS, Rambaut PC. Biochemical responses of the Skylab crewmen: an overview. In: Johnston RS, Dietlein LF, editors. Biomedical results from Skylab NASA Special Pub. SP 377. Washington, DC: National Aeronautics and Space Administration; 1977. p. 204–16.Google Scholar
  41. 41.
    Whedon GD, Lutwak L, Reid J, Rambaut PC, Whittle MW, Smith MC, et al. Mineral and nitrogen metabolic studies on Skylab orbital space flights. Trans Assoc Am Physicians. 1974;87:95–110.PubMedGoogle Scholar
  42. 42.
    Whedon G, Lutwak L, Rambaut P, Whittle M, Reid J, Smith M, et al. Mineral and nitrogen balance study observations: the second manned Skylab mission. Aviat Space Environ Med. 1976;47:391–6.PubMedGoogle Scholar
  43. 43.
    Whedon G, Heaney R. Effects of physical inactivity, paralysis and weightlessness on bone growth. In: Hall B, editor. Bone, vol. 7. Boca Raton: CRC Press; 1993. p. 57–77.Google Scholar
  44. 44.
    Elias AN, Gwinup G. Immobilization osteoporosis in paraplegia. J Am Paraplegia Soc. 1992;15:163–70.PubMedGoogle Scholar
  45. 45.
    Meythaler JM, Tuel SM, Cross LL. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. Arch Phys Med Rehabil. 1993;74:316–9.PubMedGoogle Scholar
  46. 46.
    Klein L, van der Noort S, DeJak JJ. Sequential studies of urinary hydroxyproline and serum alkaline phosphatase in acute paraplegia. Med Serv J Can. 1966;22:524–33.PubMedGoogle Scholar
  47. 47.
    Naftchi NE, Viau AT, Sell GH, Lowman EW. Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil. 1980;61:139–42.PubMedGoogle Scholar
  48. 48.
    Stewart AF, Akler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med. 1982;306:1136–40.PubMedGoogle Scholar
  49. 49.
    Minaire P, Meunier P, Edouard C, Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis: comparison with biological data. Calcif Tissue Int. 1974;17:57–73.Google Scholar
  50. 50.
    Maimoun L, Fattal C, Sultan C. Bone remodeling and calcium homeostasis in patients with spinal cord injury: a review. Metabolism. 2011;60:1655–63.PubMedGoogle Scholar
  51. 51.
    Tilton FE, Degioanni JJC, Schneider VS. Long-term follow-up of Skylab bone demineralization. Aviat Space Environ Med. 1980;51:1209–13.PubMedGoogle Scholar
  52. 52.
    Orwoll ES, Adler RA, Amin S, Binkley N, Lewiecki EM, Petak SM, et al. Skeletal health in long-duration astronauts: nature, assessment and management recommendations from the NASA bone summit. J Bone Miner Res. 2013;28:1243–55.PubMedGoogle Scholar
  53. 53.
    Smith SM, Nillen JL, LeBlanc A, Lipton A, Demers LM, Lane HW, et al. Collagen cross-link excretion during space flight and bed rest. J Clin Endocrinol Metab. 1998;83:3584–91.PubMedGoogle Scholar
  54. 54.
    Caillot-Augusseau A, Lafage-Proust MH, Soler C, Pernod J, Dubois F, Alexandre C. Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95). Clin Chem. 1998;44:578–85.PubMedGoogle Scholar
  55. 55.
    Collet P, Uebelhart D, Vico L, Moro L, Hartmann D, Roth M, et al. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans. Bone. 1997;20:547–51.PubMedGoogle Scholar
  56. 56.
    Seo H, Itoh T, Murata Y, Ohmori S, Kambe F, Mohri M, et al. Changes in urinary excretion of pyridinium cross-links during Spacelab-J. Biol Sci Space. 1997;11:321–6.PubMedGoogle Scholar
  57. 57.
    Leach C, Rambaut P, Di Ferrante N. Amino aciduria in weightlessness. Acta Astronaut. 1979;6:1323–33.PubMedGoogle Scholar
  58. 58.
    Smith BJ, Lucas EA, Turner RT, Evans GL, Lerner MR, Brackett DJ, et al. Vitamin E provides protection for bone in mature hindlimb unloaded male rats. Calcif Tissue Int. 2005;76:272–9.PubMedGoogle Scholar
  59. 59.
    Smith SM, Zwart SR, Kloeris V, Heer M. Nutritional biochemistry of space flight. New York: Nova; 2009.Google Scholar
  60. 60.
    Ihle R, Loucks AB. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res. 2004;19:1231–40.PubMedGoogle Scholar
  61. 61.
    Baek K, Barlow AA, Allen MR, Bloomfield SA. Food restriction and simulated microgravity: effects on bone and serum leptin. J Appl Physiol. 2008;104:1086–93.PubMedGoogle Scholar
  62. 62.
    Sorva A, Valimaki M, Risteli J, Risteli L, Elfving S, Takkunen H, et al. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients. Eur J Clin Invest. 1994;24:806–12.PubMedGoogle Scholar
  63. 63.
    Heer M, Boese A, Baecker N, Smith SM. High calcium intake does not prevent disuse-induced bone loss. In: 24th Annual International Gravitational Physiology Meeting, Santa Monica, CA, 4–9 May 2003.Google Scholar
  64. 64.
    Baecker N, Frings-Meuthen P, Smith SM, Heer M. Short-term high dietary calcium intake during bedrest has no effect on markers of bone turnover in healthy men. Nutrition. 2010;26:522–7.PubMedGoogle Scholar
  65. 65.
    Pavy-Le Traon A, Heer M, Narici MV, Rittweger J, Vernikos J. From space to Earth: advances in human physiology from 20 years of bed rest studies (1986-2006). Eur J Appl Physiol. 2007;101:143–94.PubMedGoogle Scholar
  66. 66.
    Convertino VA, Bloomfield SA, Greenleaf JE. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc. 1997;29:187–90.PubMedGoogle Scholar
  67. 67.
    LeBlanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM. Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res. 1990;5:843–50.PubMedGoogle Scholar
  68. 68.
    Zerwekh JE, Ruml LA, Gottschalk F, Pak CY. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998;13:1594–601.PubMedGoogle Scholar
  69. 69.
    Vico L, Chappard D, Alexandre C, Palle S, Minaire P, Riffat G, et al. Effects of a 120 day period of bed-rest on bone mass and bone cell activities in man: attempts at countermeasure. Bone Miner. 1987;2:383–94.PubMedGoogle Scholar
  70. 70.
    Spector ER, Smith SM, Sibonga JD. Skeletal effects of long-duration head-down bed rest. Aviat Space Environ Med. 2009;80:A23–8.PubMedGoogle Scholar
  71. 71.
    Morgan JL, Zwart SR, Heer M, Ploutz-Snyder R, Ericson K, Smith SM. Bone metabolism and nutritional status during 30-day head-down-tilt bed rest. J Appl Physiol. 2012;113:1519–29.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Smith SM, Zwart SR, Heer M, Lee SMC, Baecker N, Meuche S, et al. WISE-2005: supine treadmill exercise within lower body negative pressure and flywheel resistive exercise as a countermeasure to bed rest-induced bone loss in women during 60-day simulated microgravity. Bone. 2008;42:572–81.PubMedGoogle Scholar
  73. 73.
    Heer M, Baecker N, Mika C, Boese A, Gerzer R. Immobilization induces a very rapid increase in osteoclast activity. Acta Astronaut. 2005;57:31–6.PubMedGoogle Scholar
  74. 74.
    Arnaud SB, Sherrard DJ, Maloney N, Whalen RT, Fung P. Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system. Aviat Space Environ Med. 1992;63:14–20.PubMedGoogle Scholar
  75. 75.
    LeBlanc A, Schneider V, Krebs J, Evans H, Jhingran S, Johnson P. Spinal bone mineral after 5 weeks of bed rest. Calcif Tissue Int. 1987;41:259–61.PubMedGoogle Scholar
  76. 76.
    Hwang TIS, Hill K, Schneider V, Pak CYC. Effect of prolonged bedrest on the propensity for renal stone formation. J Clin Endocrinol Metab. 1988;66:109–12.PubMedGoogle Scholar
  77. 77.
    Donaldson CL, Hulley SB, Vogel JM, Hattner RS, Bayers JH, McMillan DE. Effect of prolonged bed rest on bone mineral. Metabolism. 1970;19:1071–84.PubMedGoogle Scholar
  78. 78.
    Whedon G, Lutwak L, Rambaut P, Whittle M, Leach C, Reid J, et al. Effect of weightlessness on mineral metabolism; metabolic studies on Skylab orbital flights. Calcif Tissue Res. 1976;21(Suppl):423–30.PubMedGoogle Scholar
  79. 79.
    Deitrick JE, Whedon GD, Shorr E. Effects of immobilization upon various metabolic and physiologic functions of normal men. Am J Med. 1948;4:3–36.PubMedGoogle Scholar
  80. 80.
    Zwart SR, Oliver SM, Fesperman JV, Kala G, Krauhs J, Ericson K, et al. Nutritional status assessment before, during, and after long-duration head-down bed rest. Aviat Space Environ Med. 2009;80:A15–22.PubMedGoogle Scholar
  81. 81.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol. 2007;177:2179–84.PubMedGoogle Scholar
  82. 82.
    Smith SM, Zwart SR, Heer MA, Baecker N, Evans HJ, Feiveson AH, et al. Effects of artificial gravity during bed rest on bone metabolism in humans. J Appl Physiol. 2009;107:47–53.PubMedCentralPubMedGoogle Scholar
  83. 83.
    Smith SM, Davis-Street JE, Fesperman JV, Calkins DS, Bawa M, Macias BR, et al. Evaluation of treadmill exercise in a lower body negative pressure chamber as a countermeasure for weightlessness-induced bone loss: a bed rest study with identical twins. J Bone Miner Res. 2003;18:2223–30.PubMedGoogle Scholar
  84. 84.
    Arnaud SB, Fung P, Popova IA, Morey-Holton ER, Grindeland RE. Circulating parathyroid hormone and calcitonin in rats after spaceflight. J Appl Physiol. 1992;73:169S–73.PubMedGoogle Scholar
  85. 85.
    Jowsey J, Riggs BL, Goldsmith RS, Kelly PJ, Arnaud CD. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1971;33:752–8.PubMedGoogle Scholar
  86. 86.
    Baecker N, Tomic A, Mika C, Gotzmann A, Platen P, Gerzer R, et al. Bone resorption is induced on the second day of bed rest: results of a controlled crossover trial. J Appl Physiol. 2003;95:977–82.PubMedGoogle Scholar
  87. 87.
    Frings-Meuthen P, Boehme G, Liphardt AM, Baecker N, Heer M, Rittweger J. Sclerostin and DKK1 levels during 14 and 21 days of bed rest in healthy young men. J Musculoskelet Neuronal Interact. 2013;13:45–52.PubMedGoogle Scholar
  88. 88.
    Spatz JM, Fields EE, Yu EW, Pajevic PD, Bouxsein ML, Sibonga JD, et al. Serum sclerostin increases in healthy adult men during bed rest. J Clin Endocrinol Metab. 2012;97:E1736–40.PubMedCentralPubMedGoogle Scholar
  89. 89.
    Macias BR, Swift JM, Nilsson MI, Hogan HA, Bouse SD, Bloomfield SA. Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse. J Appl Physiol. 2012;112:918–25.PubMedGoogle Scholar
  90. 90.
    Trappe S, Costill D, Gallagher P, Creer A, Peters JR, Evans H, et al. Exercise in space: human skeletal muscle after 6 months aboard the International Space Station. J Appl Physiol. 2009;106:1159–68.PubMedGoogle Scholar
  91. 91.
    Michel EL, Rummel JA, Sawin CF. Skylab experiment M-171 “Metabolic Activity”–results of the first manned mission. Acta Astronaut. 1975;2:351–65.PubMedGoogle Scholar
  92. 92.
    Michel EL, Rummel JA, Sawin CF, Buderer MC, Lem JD. Results of Skylab medical experiment M-171 - Metabolic Activity. In: Johnston RS, Dietlein LF, editors. Biomedical results of Skylab NASA SP-377. Washington, DC: NASA; 1977. p. 372–87.Google Scholar
  93. 93.
    Hawkey A. The importance of exercising in space. Interdiscip Sci Rev. 2003;28:130–8.PubMedGoogle Scholar
  94. 94.
    Convertino VA. Planning strategies for development of effective exercise and nutrition countermeasures for long-duration space flight. Nutrition. 2002;18:880–8.PubMedGoogle Scholar
  95. 95.
    Beijer A, Rosenberger A, Weber T, Zange J, May F, Schoenau E, et al. Randomized controlled study on resistive vibration exercise (EVE Study): protocol, implementation and feasibility. J Musculoskelet Neuronal Interact. 2013;13:147–56.PubMedGoogle Scholar
  96. 96.
    Macias BR, Groppo ER, Eastlack RK, Watenpaugh DE, Lee SM, Schneider SM, et al. Space exercise and Earth benefits. Curr Pharm Biotechnol. 2005;6:305–17.PubMedGoogle Scholar
  97. 97.
    Oganov VS, Bogomolov VV. Human bone system in microgravity: review of research data, hypotheses and predictability of musculoskeletal system state in extended (exploration) missions. Aviakosm Ekolog Med. 2009;43:3–12.PubMedGoogle Scholar
  98. 98.
    Cavanagh PR, Licata AA, Rice AJ. Exercise and pharmacological countermeasures for bone loss during long-duration space flight. Gravit Space Biol Bull. 2005;18:39–58.PubMedGoogle Scholar
  99. 99.
    Smith SM, Heer MA, Shackelford L, Sibonga JD, Ploutz-Snyder L, Zwart SR. Benefits for bone from resistance exercise and nutrition in long-duration spaceflight: evidence from biochemistry and densitometry. J Bone Miner Res. 2012;27:1896–906.PubMedGoogle Scholar
  100. 100.
    Smith SM, Abrams SA, Davis-Street JE, Heer M, O’Brien KO, Wastney ME, et al. 50 years of human space travel: implications for bone and calcium research. Annu Rev Nutr. 2014;34:377–400.PubMedGoogle Scholar
  101. 101.
    Shackelford LC, LeBlanc AD, Driscoll TB, Evans HJ, Rianon NJ, Smith SM, et al. Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol. 2004;97:119–29.PubMedGoogle Scholar
  102. 102.
    Vernikos J. Artificial gravity intermittent centrifugation as a space flight countermeasure. J Gravit Physiol. 1997;4:P13–6.PubMedGoogle Scholar
  103. 103.
    Clément G, Bukley AP, editors. Artificial gravity. New York: Springer; 2007.Google Scholar
  104. 104.
    Clement G, Pavy-Le TA. Centrifugation as a countermeasure during actual and simulated microgravity: a review. Eur J Appl Physiol. 2004;92:235–48.PubMedGoogle Scholar
  105. 105.
    Heer M, Baecker N, Zwart SR, Smith SM. Interactions between artificial gravity, affected physiological systems, and nutrition. In: Clement G, Bukley A, editors. Artificial gravity. New York: Springer; 2007. p. 249–70.Google Scholar
  106. 106.
    Zwart SR, Crawford GE, Gillman PL, Kala G, Rodgers AS, Rogers A, et al. Effects of 21 days of bed rest, with or without artificial gravity, on nutritional status of humans. J Appl Physiol. 2009;107:54–62.PubMedCentralPubMedGoogle Scholar
  107. 107.
    Chan ME, Uzer G, Rubin CT. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep. 2013;11:36–44.PubMedCentralPubMedGoogle Scholar
  108. 108.
    Holguin N, Muir J, Rubin C, Judex S. Short applications of very low-magnitude vibrations attenuate expansion of the intervertebral disc during extended bed rest. Spine J. 2009;9:470–7.PubMedGoogle Scholar
  109. 109.
    Armbrecht G, Belavy DL, Gast U, Bongrazio M, Touby F, Beller G, et al. Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism. Osteoporos Int. 2010;21:597–607.PubMedGoogle Scholar
  110. 110.
    Baecker N, Frings-Meuthen P, Heer M, Mester J, Liphardt AM. Effects of vibration training on bone metabolism: results from a short-term bed rest study. Eur J Appl Physiol. 2012;112:1741–50.PubMedGoogle Scholar
  111. 111.
    Belavy DL, Armbrecht G, Gast U, Richardson CA, Hides JA, Felsenberg D. Countermeasures against lumbar spine deconditioning in prolonged bed rest: resistive exercise with and without whole body vibration. J Appl Physiol. 2010;109:1801–11.PubMedGoogle Scholar
  112. 112.
    Lockwood DR, Vogel JM, Schneider VS, Hulley SB. Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. J Clin Endocrinol Metab. 1975;41:533–41.PubMedGoogle Scholar
  113. 113.
    Watanabe Y, Ohshima H, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, et al. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res. 2004;19:1771–8.PubMedGoogle Scholar
  114. 114.
    Grigoriev AI, Morukov BV, Oganov VS, Rakhmanov AS, Buravkova LB. Effect of exercise and bisphosphonate on mineral balance and bone density during 360 day antiorthostatic hypokinesia. J Bone Miner Res. 1992;7 Suppl 2:S449–55.PubMedGoogle Scholar
  115. 115.
    Thomsen JS, Morukov BV, Vico L, Alexandre C, Saparin PI, Gowin W. Cancellous bone structure of iliac crest biopsies following 370 days of head-down bed rest. Aviat Space Environ Med. 2005;76:915–22.PubMedGoogle Scholar
  116. 116.
    LeBlanc AD, Driscol TB, Shackelford LC, Evans HJ, Rianon NJ, Smith SM, et al. Alendronate as an effective countermeasure to disuse induced bone loss. J Musculoskelet Neuronal Interact. 2002;2:335–43.PubMedGoogle Scholar
  117. 117.
    Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, Brintzenhofeszoc K, et al. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int. 2007;80:316–22.PubMedGoogle Scholar
  118. 118.
    Minaire P, Berard E, Meunier PJ, Edouard C, Goedert G, Pilonchery G. Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients. J Clin Invest. 1981;68:1086–92.PubMedCentralPubMedGoogle Scholar
  119. 119.
    Maheshwari UR, Leybin L, McDonald JT, Schneider VS, Newbrun E, Hodge HC. Effect of dichloromethylene diphosphonate on fluoride balance in healthy men. J Dent Res. 1983;62:559–61.PubMedGoogle Scholar
  120. 120.
    Okada A, Ohshima H, Itoh Y, Yasui T, Tozawa K, Kohri K. Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise. Int J Urol. 2008;15:630–5.PubMedGoogle Scholar
  121. 121.
    Chappard D, Alexandre C, Palle S, Vico L, Morukov BV, Rodionova SS, et al. Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humans. Metabolism. 1989;38:822–5.PubMedGoogle Scholar
  122. 122.
    Smith SM, Zwart SR, Block G, Rice BL, Davis-Street JE. The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. J Nutr. 2005;135:437–43.PubMedGoogle Scholar
  123. 123.
    Smith SM, Gardner KK, Locke J, Zwart SR. Vitamin D supplementation during Antarctic winter. Am J Clin Nutr. 2009;89:1092–8.PubMedGoogle Scholar
  124. 124.
    Zwart SR, Mehta SK, Ploutz-Snyder R, Bourbeau Y, Locke JP, Pierson DL, et al. Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr virus reactivation. J Nutr. 2011;141:692–7.PubMedGoogle Scholar
  125. 125.
    Zwart SR, Parsons H, Kimlin M, Innis SM, Locke JP, Smith SM. A 250 μg/week dose of vitamin D was as effective as a 50 μg/d dose in healthy adults, but a regimen of four weekly followed by monthly doses of 1250 μg raised the risk of hypercalciuria. Br J Nutr. 2013;110:1866–72.PubMedGoogle Scholar
  126. 126.
    Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011.Google Scholar
  127. 127.
    Bjorkman M, Sorva A, Risteli J, Tilvis R. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing. 2008;37:25–31.PubMedGoogle Scholar
  128. 128.
    Thys-Jacobs S, Chan FKW, Koberle LMC, et al. Hypercalcemia due to vitamin D toxicity. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego, CA: Academic; 1997. p. 883–901.Google Scholar
  129. 129.
    Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr. 2007;85:6–18.PubMedGoogle Scholar
  130. 130.
    Vieth R. Vitamin D, supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–56.PubMedGoogle Scholar
  131. 131.
    Vieth R. Vitamin D, toxicity, policy, and science. J Bone Miner Res. 2007;22 Suppl 2:V64–8.PubMedGoogle Scholar
  132. 132.
    Alfrey CP, Rice L, Udden MM, Driscoll TB. Neocytolysis: physiological down-regulator of red-cell mass. Lancet. 1997;349:1389–90.PubMedGoogle Scholar
  133. 133.
    Alfrey CP, Udden MM, Leach-Huntoon C, Driscoll T, Pickett MH. Control of red blood cell mass in spaceflight. J Appl Physiol. 1996;81:98–104.PubMedGoogle Scholar
  134. 134.
    Leach CS. Biochemical and hematologic changes after short-term space flight. Microgravity Q. 1992;2:69–75.PubMedGoogle Scholar
  135. 135.
    Smith SM. Red blood cell and iron metabolism during space flight. Nutrition. 2002;18:864–6.PubMedGoogle Scholar
  136. 136.
    Lane HW, Smith SM. Nutrition in space. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. 9th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1999. p. 783–8.Google Scholar
  137. 137.
    Leach C, Rambaut P. Biochemical observations of long duration manned orbital spaceflight. J Am Med Womens Assoc. 1975;30:153–72.PubMedGoogle Scholar
  138. 138.
    Convertino VA. Clinical aspects of the control of plasma volume at microgravity and during return to one gravity. Med Sci Sports Exerc. 1996;28:S45–52.PubMedGoogle Scholar
  139. 139.
    Lane HW, Alfrey CP, Driscoll TB, Smith SM, Nyquist LE. Control of red blood cell mass during spaceflight. J Gravit Physiol. 1996;3:87–8.PubMedGoogle Scholar
  140. 140.
    Zwart SR, Morgan JL, Smith SM. Iron status and its relations with oxidative damage and bone loss during long-duration space flight on the International Space Station. Am J Clin Nutr. 2013;98:217–23.PubMedGoogle Scholar
  141. 141.
    Beilby J, Olynyk J, Ching S, Prins A, Swanson N, Reed W, et al. Transferrin index: an alternative method for calculating the iron saturation of transferrin. Clin Chem. 1992;38:2078–81.PubMedGoogle Scholar
  142. 142.
    Mendes JFR, Arrruda SF, de Almeida Siquira EM, Ito MK, da Silva EF. Iron status and oxidative stress biomarkers in adults: a preliminary study. Nutrition. 2009;25:379–84.PubMedGoogle Scholar
  143. 143.
    Tuomainen TP, Loft S, Nyyssonen K, Punnonen K, Salonen JT, Poulsen HE. Body iron is a contributor to oxidative damage of DNA. Free Radic Res. 2007;41:324–8.PubMedGoogle Scholar
  144. 144.
    Syrovatka P, Kraml P, Potockova J, Fialova L, Vejrazka M, Crkovska J, et al. Relationship between increased body iron stores, oxidative stress and insulin resistance in healthy men. Ann Nutr Metab. 2009;54:268–74.PubMedGoogle Scholar
  145. 145.
    Fernandes G, Lawrence R, Sun D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids. 2003;68:361–72.PubMedGoogle Scholar
  146. 146.
    Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 2007;6:2–10.PubMedCentralPubMedGoogle Scholar
  147. 147.
    Orchard TS, Ing SW, Lu B, Belury MA, Johnson K, Wactawski-Wende J, et al. The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women’s health initiative. J Bone Miner Res. 2013;28:505–15.PubMedCentralPubMedGoogle Scholar
  148. 148.
    Weiss LA, Barrett-Connor E, von Muhlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr. 2005;81:934–8.PubMedGoogle Scholar
  149. 149.
    Nieves JW. Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int. 2013;24:771–86.PubMedGoogle Scholar
  150. 150.
    Alexander JW. Immunonutrition: the role of omega-3 fatty acids. Nutrition. 1998;14:627–33.PubMedGoogle Scholar
  151. 151.
    Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res. 2003;18:1206–16.PubMedGoogle Scholar
  152. 152.
    Yaqoob P, Calder PC. N-3 polyunsaturated fatty acids and inflammation in the arterial wall. Eur J Med Res. 2003;8:337–54.PubMedGoogle Scholar
  153. 153.
    Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr. 2009;1–5.Google Scholar
  154. 154.
    Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc. 2009;109:668–79.PubMedGoogle Scholar
  155. 155.
    Nakamura H, Aoki K, Masuda W, Alles N, Nagano K, Fukushima H, et al. Disruption of NF-kappaB1 prevents bone loss caused by mechanical unloading. J Bone Miner Res. 2013;28:1457–67.PubMedGoogle Scholar
  156. 156.
    Moon DO, Kim KC, Jin CY, Han MH, Park C, Lee KJ, et al. Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int Immunopharmacol. 2007;7:222–9.PubMedGoogle Scholar
  157. 157.
    Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 2008;214:201–9.PubMedGoogle Scholar
  158. 158.
    Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005;3:209–17.PubMedGoogle Scholar
  159. 159.
    Kim HH, Lee Y, Eun HC, Chung JH. Eicosapentaenoic acid inhibits TNF-alpha-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells. Biochem Biophys Res Commun. 2008;368:343–9.PubMedGoogle Scholar
  160. 160.
    Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun. 1996;229:643–7.PubMedGoogle Scholar
  161. 161.
    Zwart SR, Pierson D, Mehta S, Gonda S, Smith SM. Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts. J Bone Miner Res. 2010;25:1049–57.PubMedGoogle Scholar
  162. 162.
    Thorpe MP, Evans EM. Dietary protein and bone health: harmonizing conflicting theories. Nutr Rev. 2011;69:215–30.PubMedGoogle Scholar
  163. 163.
    Jesudason D, Clifton P. The interaction between dietary protein and bone health. J Bone Miner Metab. 2010;29:1–14.PubMedGoogle Scholar
  164. 164.
    Geinoz G, Rapin CH, Rizzoli R, Kraemer R, Buchs B, Slosman D, et al. Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int. 1993;3:242–8.PubMedGoogle Scholar
  165. 165.
    Lemann Jr J, Lennon EJ. Role of diet, gastrointestinal tract and bone in acid-base homeostasis. Kidney Int. 1972;1:275–9.PubMedGoogle Scholar
  166. 166.
    Dwyer J, Foulkes E, Evans M, Ausman L. Acid/alkaline ash diets: time for assessment and change. J Am Diet Assoc. 1985;85:841–5.PubMedGoogle Scholar
  167. 167.
    Zwart SR, Hargens AR, Smith SM. The ratio of animal protein intake to potassium intake is a predictor of bone resorption in space flight analogues and in ambulatory subjects. Am J Clin Nutr. 2004;80:1058–65.PubMedGoogle Scholar
  168. 168.
    Zwart SR, Hargens AR, Lee SM, Macias BR, Watenpaugh DE, Tse K, et al. Lower body negative pressure treadmill exercise as a countermeasure for bed rest-induced bone loss in female identical twins. Bone. 2007;40:529–37.PubMedCentralPubMedGoogle Scholar
  169. 169.
    Dawson-Hughes B. Calcium and protein in bone health. Proc Nutr Soc. 2003;62:505–9.PubMedGoogle Scholar
  170. 170.
    Dawson-Hughes B. Interaction of dietary calcium and protein in bone health in humans. J Nutr. 2003;133:852S–4.PubMedGoogle Scholar
  171. 171.
    Zwart SR, Davis-Street JE, Paddon-Jones D, Ferrando AA, Wolfe RR, Smith SM. Amino acid supplementation alters bone metabolism during simulated weightlessness. J Appl Physiol. 2005;99:134–40.PubMedGoogle Scholar
  172. 172.
    Vormann J, Remer T. Dietary, metabolic, physiologic, and disease-related aspects of acid-base balance: foreword to the contributions of the second International Acid-Base Symposium. J Nutr. 2008;138:413S–4.PubMedGoogle Scholar
  173. 173.
    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.PubMedCentralPubMedGoogle Scholar
  174. 174.
    Bedford JL, Barr SI. Higher urinary sodium, a proxy for intake, is associated with increased calcium excretion and lower hip bone density in healthy young women with lower calcium intakes. Nutrients. 2011;3:951–61.PubMedCentralPubMedGoogle Scholar
  175. 175.
    Devine A, Criddle RA, Dick IM, Kerr DA, Prince RL. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr. 1995;62:740–5.PubMedGoogle Scholar
  176. 176.
    Heaney RP. Role of dietary sodium in osteoporosis. J Am Coll Nutr. 2006;25:271S–6.PubMedGoogle Scholar
  177. 177.
    Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens. 2004;13:423–36.PubMedGoogle Scholar
  178. 178.
    Zarkadas M, Gougeon-Reyburn R, Marliss EB, Block E, Alton-Mackey M. Sodium chloride supplementation and urinary calcium excretion in postmenopausal women. Am J Clin Nutr. 1989;50:1088–94.PubMedGoogle Scholar
  179. 179.
    Frings-Meuthen P, Baecker N, Heer M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J Bone Miner Res. 2008;23:517–24.PubMedGoogle Scholar
  180. 180.
    Heer M, Frings-Meuthen P, Titze J, Boschmann M, Frisch S, Baecker N, et al. Increasing sodium intake from a previous low or high intake affects water, electrolyte and acid-base differently. Br J Nutr. 2009;101:1286–94.PubMedGoogle Scholar
  181. 181.
    Frassetto LA, Morris Jr RC, Sellmeyer DE, Sebastian A. Adverse effects of sodium chloride on bone in the aging human population resulting from habitual consumption of typical American diets. J Nutr. 2008;138:419S–22.PubMedGoogle Scholar
  182. 182.
    Bushinsky DA, Wolbach W, Sessler NE, Mogilevsky R, Levi-Setti R. Physicochemical effects of acidosis on bone calcium flux and surface ion composition. J Bone Miner Res. 1993;8:93–102.PubMedGoogle Scholar
  183. 183.
    Bushinsky DA, Ori Y. Effects of metabolic and respiratory acidosis on bone. Curr Opin Nephrol Hypertens. 1993;2:588–96.PubMedGoogle Scholar
  184. 184.
    Arnett TR. Acid-base regulation of bone metabolism. In: Burckhardt P, Heaney RP, Dawson-Hughes B, editors. Nutritional aspects of osteoporosis. New York: Elsevier; 2007. p. 255–67.Google Scholar
  185. 185.
    Caillot-Augusseau A, Vico L, Heer M, Voroviev D, Souberbielle J-C, Zitterman A, et al. Space flight is associated with rapid decreases of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variation: observations in two cosmonauts. Clin Chem. 2000;46:1136–43.PubMedGoogle Scholar
  186. 186.
    Frings-Meuthen P, Buehlmeier J, Baecker N, Stehle P, Fimmers R, May F, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol. 2011;111:537–42.PubMedGoogle Scholar
  187. 187.
    Bugel S. Vitamin K, and bone health in adult humans. Vitam Horm. 2008;78:393–416.PubMedGoogle Scholar
  188. 188.
    Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr. 2012;3:149–57.PubMedCentralPubMedGoogle Scholar
  189. 189.
    Gundberg CM. Vitamin K, and bone: past, present, and future. J Bone Miner Res. 2009;24:980–2.PubMedGoogle Scholar
  190. 190.
    Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyak K, Gerichhausen MJ, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. 2003;73:21–6.PubMedGoogle Scholar
  191. 191.
    Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res. 2009;24:983–91.PubMedCentralPubMedGoogle Scholar
  192. 192.
    Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab. 2008;93:1217–23.PubMedCentralPubMedGoogle Scholar
  193. 193.
    Vermeer C, Wolf J, Craciun AM, Knapen MH. Bone markers during a 6-month space flight: effects of vitamin K supplementation. J Gravit Physiol. 1998;5:65–9.PubMedGoogle Scholar
  194. 194.
    Zwart SR, Booth SL, Peterson JW, Wang Z, Smith SM. Vitamin K status in spaceflight and ground-based models of spaceflight. J Bone Miner Res. 2011;26:948–54.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Human Health and Performance DirectorateNASA Lyndon B. Johnson Space CenterHoustonUSA
  2. 2.Department of Nutrition and Food Science, Nutrition PhysiologyUniversity of BonnBonnGermany
  3. 3.Division of Space Life SciencesUniversities Space Research AssociationHoustonUSA

Personalised recommendations